Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,028.00
Bid: 12,032.00
Ask: 12,036.00
Change: 98.00 (0.82%)
Spread: 4.00 (0.033%)
Open: 12,108.00
High: 12,142.00
Low: 11,994.00
Prev. Close: 11,930.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

Tue, 02nd Jan 2024 07:57

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

The London Stock Exchange will reopen today after being closed for New Year's Day on Monday.

Manufacturing PMI data will be released for the UK at 0930 GMT, alongside figures for the EU and Germany in the morning, followed by US data in the afternoon.

In corporate news, AstraZeneca said that its and Sanofi's Beyfortus treatment has been approved in China, while Airtel Africa's chief executive will retire, with the firm promoting a successor from within.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 0.2% at 7,749.84

----------

Hang Seng: down 1.6% at 16,769.35

Nikkei 225: financial markets in Japan closed for New Year holiday

S&P/ASX 200: closed up 0.5% at 7,627.80

----------

DJIA: closed down 20.56 points, or 0.1%, at 37,689.54

S&P 500: closed down 13.52 points, or 0.3%, at 4,769.83

Nasdaq Composite: closed down 83.78 points, or 0.6%, to 15,011.35

----------

EUR: down at USD1.1033 (USD1.1074)

GBP: down at USD1.2736 (USD1.2747)

USD: up at JPY141.46 (JPY141.42)

Gold: up at USD2,074.88 per ounce (USD2,065.02)

Oil (Brent): up at USD78.29 a barrel (USD77.56)

(changes since previous London equities close)

----------

ECONOMICS

----------

Tuesday's key economic events still to come:

09:55 CET Germany manufacturing PMI

10:00 CET EU manufacturing PMI

09:30 GMT UK manufacturing PMI

09:45 EST US manufacturing PMI

----------

UK shop price inflation was unchanged at 4.3% in December, its lowest in a year and a half, but the British Retail Consortium warned that cost pressures threaten to put an end to easing inflation in 2024. The BRC-NielsenIQ shop price index was up 4.3% in December from a year before, the annual rise slower than the three-month average rate of 4.6% and the lowest since June 2022. Food price inflation slowed to 6.7% last month from 7.8% in November. Fresh food price rose by 5.4% annually in December, slowing from 6.7% the month before, while ambient food inflation slowed to 8.4% from 9.2%. However, non-food price inflation picked up to 3.1% in December from 2.5% in November.

----------

COMPANIES - FTSE 100

----------

AstraZeneca said its and Sanofi's long-acting monoclonal antibody treatment Beyfortus has been approved in China for the prevention of respiratory syncytial virus lower respiratory tract infection in neonates and infants. The Cambridge-based pharmaceutical firm said the approval by China's National Medical Products Administration is based on three "pivotal" late-stage clinical trials and an "extensive" local clinical development programme. It is anticipated to be available during the upcoming 2024/25 RSV season. Beyfortus was approved in the EU in October 2022 and received approval by the US Food & Drug Administration in July 2023 following the unanimous recommendation by the Antimicrobial Drugs Advisory Committee in June 2023. AstraZeneca said regulatory applications are currently under review in Japan and "several other countries".

----------

Airtel Africa announced the retirement of Chief Executive Officer Segun Ogunsanya, naming Transformation Director Sunil Taldar as his successor. Taldar joined the telecommunications company in October and will be appointed to the board as CEO and executive director following a transition period at the beginning of July. At this time, Ogunsanya will formally retire but will be available to advise Chair Sunil Bharti Mittal, the board and incoming CEO Taldar for a 12-month period. Mittal said: "Under Segun's leadership, Airtel Africa has maintained double-digit revenue growth and continued to deliver new, industry-leading products to our customers across Africa...[Taldar's] industry experience, strategic vision, constant customer focus and proven record of delivery will enable him to deliver our strategic objectives and to lead the group in the next stages of its development."

----------

Outgoing BT Chief Philip Jansen has been approached about the next chair of marketing services firm WPP, according to a report from Sky News on Monday. Jansen, who is set to leave BT in the spring, is reportedly one of a number of candidates to have been considered in recent weeks for the WPP chairmanship. City sources on Monday said WPP's search was yet to reach an advanced stage and that there was no certainty that Jansen or WPP would opt to progress his candidacy further.

----------

COMPANIES - FTSE 250

----------

Balfour Beatty said it has appointed corporate brokers to manage an initial tranche of its 2024 share buyback programme, repurchasing up to GBP50 million or 63.2 million shares. The infrastructure construction firm intends for this initial tranche to be completed by the end of June, while the total anticipated 2024 share buyback will be confirmed with the firm's full year results in March.

----------

OTHER COMPANIES

----------

Zanaga said it has agreed a loan repayment extension with FTSE 100-listed mining firm Glencore to the end of March from the end of December. In June, both parties entered into a loan facility agreement, under which a loan of up to USD1.8 million would be provided to Zanaga's partially-owned subsidiary Jumelles by Glencore to provide funding for ongoing working capital required to progress initiatives at the Zanaga project. Zanaga has already paid USD463,000 of the loan facility. Zanaga Chair Clifford Elphick said: "ZIOC is pleased with the ongoing progress being made in advancing discussions with potential partners, and as part of ZIOC's strategic objectives has already recently concluded an [memorandum of understanding] relating to power solutions for the Zanaga project. We look forward to progressing further strategic initiatives in early 2024."

----------

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more
19 Feb 2024 08:03

AstraZeneca's Tagrisso gains FDA approval

(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.